What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Pharmaceutical

Respiratory

PUBLISHER: TechNavio | PRODUCT CODE: 1756603

PUBLISHER: TechNavio | PRODUCT CODE: 1756603

Global Pulmonary Embolism Therapeutics Market 2025-2029

PUBLISHED: June 12, 2025

PAGES: 206 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The pulmonary embolism therapeutics market is forecasted to grow by USD 16,693.4 mn during 2024-2029, accelerating at a CAGR of 11.7% during the forecast period. The report on the pulmonary embolism therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing risk of adverse health conditions, increase in geriatric population, and rise in research and development activities for pulmonary embolism therapeutics.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	10.2%
CAGR	11.7%
Incremental Value	$16,693.4 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's pulmonary embolism therapeutics market is segmented as below:

By Application

Hospitals
Ambulatory surgical centers
Research institutes

By Route Of Administration

Oral
Parenteral

By Drug Class

Direct oral anticoagulants (DOACs)
Heparins vitamin K
Antagonists

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the advancements in healthcare and medical sector as one of the prime reasons driving the pulmonary embolism therapeutics market growth during the next few years. Also, increasing awareness regarding pulmonary embolism and growing number of partnerships and collaborations on therapeutics will lead to sizable demand in the market.

The report on the pulmonary embolism therapeutics market covers the following areas:

Pulmonary Embolism Therapeutics Market sizing
Pulmonary Embolism Therapeutics Market forecast
Pulmonary Embolism Therapeutics Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pulmonary embolism therapeutics market vendors that include AbbVie Inc., Astellas Pharma Inc., Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., F. Hoffmann La Roche Ltd., Inari Medical Inc., Johnson and Johnson Services Inc., Medtronic Plc, Novartis AG, Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and Viatris Inc.. Also, the pulmonary embolism therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR75721

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Pulmonary Embolism Therapeutics Market 2019 - 2023
- Historic Market Size - Data Table on Global Pulmonary Embolism Therapeutics Market 2019 - 2023 ($ million)
5.2 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ million)
5.3 Route of Administration segment analysis 2019 - 2023
- Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
5.4 Drug Class segment analysis 2019 - 2023
- Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 The AI impact on global pulmonary embolism therapeutics market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Application

8.1 Market segments
- Chart on Application - Market share 2024-2029 (%)
- Data Table on Application - Market share 2024-2029 (%)
8.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
8.3 Hospitals - Market size and forecast 2024-2029
- Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
- Chart on Hospitals - Year-over-year growth 2024-2029 (%)
- Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
8.4 Ambulatory surgical centers - Market size and forecast 2024-2029
- Chart on Ambulatory surgical centers - Market size and forecast 2024-2029 ($ million)
- Data Table on Ambulatory surgical centers - Market size and forecast 2024-2029 ($ million)
- Chart on Ambulatory surgical centers - Year-over-year growth 2024-2029 (%)
- Data Table on Ambulatory surgical centers - Year-over-year growth 2024-2029 (%)
8.5 Research institutes - Market size and forecast 2024-2029
- Chart on Research institutes - Market size and forecast 2024-2029 ($ million)
- Data Table on Research institutes - Market size and forecast 2024-2029 ($ million)
- Chart on Research institutes - Year-over-year growth 2024-2029 (%)
- Data Table on Research institutes - Year-over-year growth 2024-2029 (%)
8.6 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)

9 Market Segmentation by Route of Administration

9.1 Market segments
- Chart on Route of Administration - Market share 2024-2029 (%)
- Data Table on Route of Administration - Market share 2024-2029 (%)
9.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
9.3 Oral - Market size and forecast 2024-2029
- Chart on Oral - Market size and forecast 2024-2029 ($ million)
- Data Table on Oral - Market size and forecast 2024-2029 ($ million)
- Chart on Oral - Year-over-year growth 2024-2029 (%)
- Data Table on Oral - Year-over-year growth 2024-2029 (%)
9.4 Parenteral - Market size and forecast 2024-2029
- Chart on Parenteral - Market size and forecast 2024-2029 ($ million)
- Data Table on Parenteral - Market size and forecast 2024-2029 ($ million)
- Chart on Parenteral - Year-over-year growth 2024-2029 (%)
- Data Table on Parenteral - Year-over-year growth 2024-2029 (%)
9.5 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)

10 Market Segmentation by Drug Class

10.1 Market segments
- Chart on Drug Class - Market share 2024-2029 (%)
- Data Table on Drug Class - Market share 2024-2029 (%)
10.2 Comparison by Drug Class
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class
10.3 Direct oral anticoagulants (DOACs) - Market size and forecast 2024-2029
- Chart on Direct oral anticoagulants (DOACs) - Market size and forecast 2024-2029 ($ million)
- Data Table on Direct oral anticoagulants (DOACs) - Market size and forecast 2024-2029 ($ million)
- Chart on Direct oral anticoagulants (DOACs) - Year-over-year growth 2024-2029 (%)
- Data Table on Direct oral anticoagulants (DOACs) - Year-over-year growth 2024-2029 (%)
10.4 Heparins vitamin K - Market size and forecast 2024-2029
- Chart on Heparins vitamin K - Market size and forecast 2024-2029 ($ million)
- Data Table on Heparins vitamin K - Market size and forecast 2024-2029 ($ million)
- Chart on Heparins vitamin K - Year-over-year growth 2024-2029 (%)
- Data Table on Heparins vitamin K - Year-over-year growth 2024-2029 (%)
10.5 Antagonists - Market size and forecast 2024-2029
- Chart on Antagonists - Market size and forecast 2024-2029 ($ million)
- Data Table on Antagonists - Market size and forecast 2024-2029 ($ million)
- Chart on Antagonists - Year-over-year growth 2024-2029 (%)
- Data Table on Antagonists - Year-over-year growth 2024-2029 (%)
10.6 Market opportunity by Drug Class
- Market opportunity by Drug Class ($ million)
- Data Table on Market opportunity by Drug Class ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.9 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
12.10 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.11 Norway - Market size and forecast 2024-2029
- Chart on Norway - Market size and forecast 2024-2029 ($ million)
- Data Table on Norway - Market size and forecast 2024-2029 ($ million)
- Chart on Norway - Year-over-year growth 2024-2029 (%)
- Data Table on Norway - Year-over-year growth 2024-2029 (%)
12.12 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
12.13 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
12.14 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
12.15 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.16 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- SWOT
15.5 Astellas Pharma Inc.
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product / Service
- Astellas Pharma Inc. - Key offerings
- SWOT
15.6 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
15.7 Boehringer Ingelheim International GmbH
- Boehringer Ingelheim International GmbH - Overview
- Boehringer Ingelheim International GmbH - Product / Service
- Boehringer Ingelheim International GmbH - Key news
- Boehringer Ingelheim International GmbH - Key offerings
- SWOT
15.8 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- SWOT
15.9 Daiichi Sankyo Co. Ltd.
- Daiichi Sankyo Co. Ltd. - Overview
- Daiichi Sankyo Co. Ltd. - Product / Service
- Daiichi Sankyo Co. Ltd. - Key offerings
- SWOT
15.10 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
15.11 Inari Medical Inc.
- Inari Medical Inc. - Overview
- Inari Medical Inc. - Product / Service
- Inari Medical Inc. - Key offerings
- SWOT
15.12 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
- SWOT
15.13 Medtronic Plc
- Medtronic Plc - Overview
- Medtronic Plc - Business segments
- Medtronic Plc - Key news
- Medtronic Plc - Key offerings
- Medtronic Plc - Segment focus
- SWOT
15.14 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
15.15 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
15.16 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
15.17 Takeda Pharmaceutical Co. Ltd.
- Takeda Pharmaceutical Co. Ltd. - Overview
- Takeda Pharmaceutical Co. Ltd. - Product / Service
- Takeda Pharmaceutical Co. Ltd. - Key news
- Takeda Pharmaceutical Co. Ltd. - Key offerings
- SWOT
15.18 Viatris Inc.
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
- SWOT

16 Appendix

16.1 Scope of the report
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations

Product Code: IRTNTR75721

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits8: Executive Summary - Chart on Incremental Growth
Exhibits9: Executive Summary - Data Table on Incremental Growth
Exhibits10: Executive Summary - Chart on Company Market Positioning
Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits12: Overview on criticality of inputs and factors of differentiation
Exhibits13: Overview on factors of disruption
Exhibits14: Impact of drivers and challenges in 2024 and 2029
Exhibits15: Parent Market
Exhibits16: Data Table on - Parent Market
Exhibits17: Market characteristics analysis
Exhibits18: Value chain analysis
Exhibits19: Offerings of companies included in the market definition
Exhibits20: Market segments
Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits25: Historic Market Size - Data Table on Global Pulmonary Embolism Therapeutics Market 2019 - 2023 ($ million)
Exhibits26: Historic Market Size - Application Segment 2019 - 2023 ($ million)
Exhibits27: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
Exhibits28: Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits31: Five forces analysis - Comparison between 2024 and 2029
Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits37: Chart on Market condition - Five forces 2024 and 2029
Exhibits38: Chart on Application - Market share 2024-2029 (%)
Exhibits39: Data Table on Application - Market share 2024-2029 (%)
Exhibits40: Chart on Comparison by Application
Exhibits41: Data Table on Comparison by Application
Exhibits42: Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibits43: Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibits44: Chart on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibits45: Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibits46: Chart on Ambulatory surgical centers - Market size and forecast 2024-2029 ($ million)
Exhibits47: Data Table on Ambulatory surgical centers - Market size and forecast 2024-2029 ($ million)
Exhibits48: Chart on Ambulatory surgical centers - Year-over-year growth 2024-2029 (%)
Exhibits49: Data Table on Ambulatory surgical centers - Year-over-year growth 2024-2029 (%)
Exhibits50: Chart on Research institutes - Market size and forecast 2024-2029 ($ million)
Exhibits51: Data Table on Research institutes - Market size and forecast 2024-2029 ($ million)
Exhibits52: Chart on Research institutes - Year-over-year growth 2024-2029 (%)
Exhibits53: Data Table on Research institutes - Year-over-year growth 2024-2029 (%)
Exhibits54: Market opportunity by Application ($ million)
Exhibits55: Data Table on Market opportunity by Application ($ million)
Exhibits56: Chart on Route of Administration - Market share 2024-2029 (%)
Exhibits57: Data Table on Route of Administration - Market share 2024-2029 (%)
Exhibits58: Chart on Comparison by Route of Administration
Exhibits59: Data Table on Comparison by Route of Administration
Exhibits60: Chart on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits61: Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits62: Chart on Oral - Year-over-year growth 2024-2029 (%)
Exhibits63: Data Table on Oral - Year-over-year growth 2024-2029 (%)
Exhibits64: Chart on Parenteral - Market size and forecast 2024-2029 ($ million)
Exhibits65: Data Table on Parenteral - Market size and forecast 2024-2029 ($ million)
Exhibits66: Chart on Parenteral - Year-over-year growth 2024-2029 (%)
Exhibits67: Data Table on Parenteral - Year-over-year growth 2024-2029 (%)
Exhibits68: Market opportunity by Route of Administration ($ million)
Exhibits69: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits70: Chart on Drug Class - Market share 2024-2029 (%)
Exhibits71: Data Table on Drug Class - Market share 2024-2029 (%)
Exhibits72: Chart on Comparison by Drug Class
Exhibits73: Data Table on Comparison by Drug Class
Exhibits74: Chart on Direct oral anticoagulants (DOACs) - Market size and forecast 2024-2029 ($ million)
Exhibits75: Data Table on Direct oral anticoagulants (DOACs) - Market size and forecast 2024-2029 ($ million)
Exhibits76: Chart on Direct oral anticoagulants (DOACs) - Year-over-year growth 2024-2029 (%)
Exhibits77: Data Table on Direct oral anticoagulants (DOACs) - Year-over-year growth 2024-2029 (%)
Exhibits78: Chart on Heparins vitamin K - Market size and forecast 2024-2029 ($ million)
Exhibits79: Data Table on Heparins vitamin K - Market size and forecast 2024-2029 ($ million)
Exhibits80: Chart on Heparins vitamin K - Year-over-year growth 2024-2029 (%)
Exhibits81: Data Table on Heparins vitamin K - Year-over-year growth 2024-2029 (%)
Exhibits82: Chart on Antagonists - Market size and forecast 2024-2029 ($ million)
Exhibits83: Data Table on Antagonists - Market size and forecast 2024-2029 ($ million)
Exhibits84: Chart on Antagonists - Year-over-year growth 2024-2029 (%)
Exhibits85: Data Table on Antagonists - Year-over-year growth 2024-2029 (%)
Exhibits86: Market opportunity by Drug Class ($ million)
Exhibits87: Data Table on Market opportunity by Drug Class ($ million)
Exhibits88: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits89: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits90: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits91: Chart on Geographic comparison
Exhibits92: Data Table on Geographic comparison
Exhibits93: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits94: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits95: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits96: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits97: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits98: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits99: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits100: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits101: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits102: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits103: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits104: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits105: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits106: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits107: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits108: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits109: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits110: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits111: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits112: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits113: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits114: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits115: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits117: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits118: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits119: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits120: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits121: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits122: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits123: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits124: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits125: Chart on Norway - Market size and forecast 2024-2029 ($ million)
Exhibits126: Data Table on Norway - Market size and forecast 2024-2029 ($ million)
Exhibits127: Chart on Norway - Year-over-year growth 2024-2029 (%)
Exhibits128: Data Table on Norway - Year-over-year growth 2024-2029 (%)
Exhibits129: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits130: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits131: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits132: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits133: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits134: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits135: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits136: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits137: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits138: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits139: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits140: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits141: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits142: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits143: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits144: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits145: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits146: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits147: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits148: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits149: Market opportunity By Geographical Landscape ($ million)
Exhibits150: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits151: Impact of drivers and challenges in 2024 and 2029
Exhibits152: Overview on criticality of inputs and factors of differentiation
Exhibits153: Overview on factors of disruption
Exhibits154: Impact of key risks on business
Exhibits155: Companies covered
Exhibits156: Company ranking index
Exhibits157: Matrix on companies position and classification
Exhibits158: AbbVie Inc. - Overview
Exhibits159: AbbVie Inc. - Product / Service
Exhibits160: AbbVie Inc. - Key news
Exhibits161: AbbVie Inc. - Key offerings
Exhibits162: SWOT
Exhibits163: Astellas Pharma Inc. - Overview
Exhibits164: Astellas Pharma Inc. - Product / Service
Exhibits165: Astellas Pharma Inc. - Key offerings
Exhibits166: SWOT
Exhibits167: Bayer AG - Overview
Exhibits168: Bayer AG - Business segments
Exhibits169: Bayer AG - Key news
Exhibits170: Bayer AG - Key offerings
Exhibits171: Bayer AG - Segment focus
Exhibits172: SWOT
Exhibits173: Boehringer Ingelheim International GmbH - Overview
Exhibits174: Boehringer Ingelheim International GmbH - Product / Service
Exhibits175: Boehringer Ingelheim International GmbH - Key news
Exhibits176: Boehringer Ingelheim International GmbH - Key offerings
Exhibits177: SWOT
Exhibits178: Bristol Myers Squibb Co. - Overview
Exhibits179: Bristol Myers Squibb Co. - Product / Service
Exhibits180: Bristol Myers Squibb Co. - Key news
Exhibits181: Bristol Myers Squibb Co. - Key offerings
Exhibits182: SWOT
Exhibits183: Daiichi Sankyo Co. Ltd. - Overview
Exhibits184: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits185: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits186: SWOT
Exhibits187: F. Hoffmann La Roche Ltd. - Overview
Exhibits188: F. Hoffmann La Roche Ltd. - Business segments
Exhibits189: F. Hoffmann La Roche Ltd. - Key news
Exhibits190: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits191: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits192: SWOT
Exhibits193: Inari Medical Inc. - Overview
Exhibits194: Inari Medical Inc. - Product / Service
Exhibits195: Inari Medical Inc. - Key offerings
Exhibits196: SWOT
Exhibits197: Johnson and Johnson Services Inc. - Overview
Exhibits198: Johnson and Johnson Services Inc. - Business segments
Exhibits199: Johnson and Johnson Services Inc. - Key news
Exhibits200: Johnson and Johnson Services Inc. - Key offerings
Exhibits201: Johnson and Johnson Services Inc. - Segment focus
Exhibits202: SWOT
Exhibits203: Medtronic Plc - Overview
Exhibits204: Medtronic Plc - Business segments
Exhibits205: Medtronic Plc - Key news
Exhibits206: Medtronic Plc - Key offerings
Exhibits207: Medtronic Plc - Segment focus
Exhibits208: SWOT
Exhibits209: Novartis AG - Overview
Exhibits210: Novartis AG - Business segments
Exhibits211: Novartis AG - Key news
Exhibits212: Novartis AG - Key offerings
Exhibits213: Novartis AG - Segment focus
Exhibits214: SWOT
Exhibits215: Pfizer Inc. - Overview
Exhibits216: Pfizer Inc. - Product / Service
Exhibits217: Pfizer Inc. - Key news
Exhibits218: Pfizer Inc. - Key offerings
Exhibits219: SWOT
Exhibits220: Sanofi SA - Overview
Exhibits221: Sanofi SA - Business segments
Exhibits222: Sanofi SA - Key news
Exhibits223: Sanofi SA - Key offerings
Exhibits224: Sanofi SA - Segment focus
Exhibits225: SWOT
Exhibits226: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits227: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits228: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits229: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits230: SWOT
Exhibits231: Viatris Inc. - Overview
Exhibits232: Viatris Inc. - Business segments
Exhibits233: Viatris Inc. - Key news
Exhibits234: Viatris Inc. - Key offerings
Exhibits235: Viatris Inc. - Segment focus
Exhibits236: SWOT
Exhibits237: Inclusions checklist
Exhibits238: Exclusions checklist
Exhibits239: Currency conversion rates for US$
Exhibits240: Research methodology
Exhibits241: Information sources
Exhibits242: Data validation
Exhibits243: Validation techniques employed for market sizing
Exhibits244: Data synthesis
Exhibits245: 360 degree market analysis
Exhibits246: List of abbreviations